News about "GSK"

GSK Completes Acquisition of IDRx

GSK Completes Acquisition of IDRx

IDRX-42 has demonstrated activity against all clinically relevant primary and secondary KIT mutations, a key medical need in current GIST treatment.

GSK | 25/02/2025 | By Aishwarya

Muna Therapeutics Partners with GSK to Develop Novel Treatments for Alzheimer's Disease

Muna Therapeutics Partners with GSK to Develop Novel Treatments for Alzheimer's Disease

Together, Muna and GSK will assess postmortem human brain samples with spatial transcriptomics and other approaches to identify and validate potential new drug targets.

GSK | 06/12/2024 | By Aishwarya

GSK Announces Positive Data for Arexvy (RSV) Vaccine

GSK Announces Positive Data for Arexvy (RSV) Vaccine

Arexvy is the world’s first RSV vaccine and was approved based on exceptional efficacy in adults aged 60 and older, including those who are at increased risk due to certain underlying medical conditions.

GSK | 10/10/2024 | By Aishwarya

BioVersys Extends its Strategic Collaboration with GSK

BioVersys Extends its Strategic Collaboration with GSK

BioVersys has extended its strategic collaboration with the global biopharma company GSK to accelerate the clinical development of alpibectir (BVL-GSK098) for the treatment of tuberculosis (TB).

GSK | 09/05/2024 | By Aishwarya 192

Pharma giant GSK to build Singapore facility making Hepatitis B vaccine

Pharma giant GSK to build Singapore facility making Hepatitis B vaccine

Pharma giant GSK to build Singapore facility making Hepatitis B vaccine

GSK | 14/07/2023 | By Sudeep Soparkar 299

GSK in agreement to acquire late-stage biopharma company BELLUS Health

GSK in agreement to acquire late-stage biopharma company BELLUS Health

The acquisition provides GSK access to camlipixant, a potential best-in-class and highly selective P2X3 antagonist currently in phase III development for the first-line treatment of adult patients with RCC

GSK | 25/04/2023 | By Sudeep Soparkar 506

GSK introduces Shingrix vaccine in India

GSK introduces Shingrix vaccine in India

Shingrix is the world’s first non-live, recombinant subunit vaccine to be given intramuscularly in two doses

GSK | 25/04/2023 | By Sudeep Soparkar 1154

CCI approves acquisition of corporate restructuring of GlaxoSmithKline Consumer Healthcare Holdings

CCI approves acquisition of corporate restructuring of GlaxoSmithKline Consumer Healthcare Holdings

The proposed combination involves corporate restructuring of JVCO, including through acquisition by Haleon via demerger and the share exchange steps involving the shareholders of JVCO

GSK | 15/06/2022 | By Sudeep Soparkar 212


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members